topotecan has been researched along with Choroid Plexus Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, E; Dahmane, N; Garman, T; Hagen, N; Holland, D; Klumpp-Thomas, C; Laramee, M; Martin, B; McKnight, C; Souweidane, M; Thomas, CJ; Wang, A; Wilson, K; Xu, X; Zhang, X | 1 |
| Fels, C; Hau, P; Janssen, G; Liebeskind, AK; Peters, O; Sauerbrey, A; Suttorp, M; Wagner, S; Wolff, JE | 1 |
1 trial(s) available for topotecan and Choroid Plexus Neoplasms
| Article | Year |
|---|---|
Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Child; Child, Preschool; Choroid Plexus Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Eruptions; Glioblastoma; Hematologic Diseases; Humans; Neoplasm Recurrence, Local; Polyethylene Glycols; Recurrence; Retrospective Studies; Stomatitis; Topotecan; Treatment Outcome | 2008 |
1 other study(ies) available for topotecan and Choroid Plexus Neoplasms
| Article | Year |
|---|---|
Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.
Topics: Animals; Carcinoma; Child; Choroid Plexus Neoplasms; Humans; Mammals; Melphalan; Mice; Topotecan | 2023 |